Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 433,584 | 113,432 | 100,488 | 162,531 | 93,719 |
| Marketable Securities | 321,646 | 346,274 | 134,005 | 219,028 | 343,428 |
| Receivables | 32,844 | 12,740 | 5,172 | N/A | N/A |
| Inventories | 11,546 | 7,065 | 757 | N/A | N/A |
| TOTAL | $851,017 | $522,369 | $269,583 | $401,695 | $450,207 |
| Non-Current Assets | |||||
| PPE Net | 44,348 | 20,046 | 21,837 | 17,055 | 7,373 |
| Investments And Advances | 32,926 | 0 | 9,975 | 117,963 | 99,259 |
| Intangibles | 173,406 | 173,629 | 185,951 | 0 | 0 |
| Other Non-Current Assets | 33,799 | 3,514 | 3,407 | 3,913 | 2,730 |
| TOTAL | $284,479 | $197,189 | $221,170 | $138,931 | $109,362 |
| Total Assets | $1,135,496 | $719,558 | $490,753 | $540,626 | $559,569 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,871 | 12,275 | 8,886 | 5,364 | 2,942 |
| Accrued Expenses | 83,194 | 62,450 | 62,128 | 54,554 | 24,784 |
| TOTAL | $103,300 | $74,725 | $71,014 | $60,259 | $27,918 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 341 | 192 |
| Other Non-Current Liabilities | 345,126 | 4,759 | 5,119 | 6,393 | 561 |
| TOTAL | $378,432 | $35,925 | $36,285 | $6,393 | $561 |
| Total Liabilities | $481,732 | $110,650 | $107,299 | $66,652 | $28,479 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,889 | 51,279 | 49,606 | 41,727 | 38,980 |
| Common Shares | 58 | 51 | 44 | 41 | 39 |
| Retained earnings | -1,433,010 | -1,030,283 | -832,672 | -530,533 | -284,659 |
| Other shareholders' equity | -147 | -633 | -5,680 | 905 | -868 |
| TOTAL | $653,764 | $608,908 | $383,454 | $473,974 | $531,090 |
| Total Liabilities And Equity | $1,135,496 | $719,558 | $490,753 | $540,626 | $559,569 |